The purpose of this study is to assess the Efficacy, Long Term Safety and Tolerability of RT001 in subjects with Friedreich's Ataxia
Open Actively Recruiting
Monday, July 19, 2021
A Study to Assess Efficacy, Long Term Safety and Tolerability of RT001 in Subjects With Friedreich's Ataxia
UCLA Health, NCT No. NCT04102501; Phase 3
Subscribe to:
Posts (Atom)
